Showing results (231-240 of 1,353) with videos related to

Sort By:
Pageof 136
Biochemical and Biophysical Research Communications|August 28, 1997
Genomic organization, sequence, and transcriptional regulation of the human eotaxin geneH Hein, C Schlüter, R Kulke, et al.
The British Journal of Dermatology|June 3, 1999
Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapyA Hauschild, G Engel, W Brenner, et al.
The British Journal of Dermatology|January 22, 2003
Oral lichenoid reactions associated with amalgam: improvement after amalgam removalA Dunsche, I Kästel, H Terheyden, et al.
The British Journal of Dermatology|February 17, 1999
The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusionU Mrowietz, M Graeber, M Bräutigam, et al.
Dermatology (Basel, Switzerland)|July 30, 2002
Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgarisH Gollnick, P Altmeyer, R Kaufmann, et al.
The Journal of Investigative Dermatology|March 1, 1996
Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesionsR Kulke, I Tödt-Pingel, D Rademacher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1996
Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblastsN Noso, M Sticherling, J Bartels, et al.
The Journal of Investigative Dermatology|January 10, 1998
The CXC receptor 2 is overexpressed in psoriatic epidermisR Kulke, E Bornscheuer, C Schlüter, et al.
European Journal of Biochemistry|May 13, 1998
Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-alpha-stimulated dermal fibroblastsN Noso, J Bartels, A I Mallet, et al.
Melanoma Research|October 24, 2002
Clinical evaluation of 5-S-cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanomaT Meyer, A Hauschild, A Kromminga, et al.
Pageof 136